Screener
Janux Therapeutics JANX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $936.72M.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's market capitalization?
- Janux Therapeutics (JANX) reported market capitalization of $936.72M in Q2 2026.
- How has Janux Therapeutics's market capitalization changed year-over-year?
- Janux Therapeutics's market capitalization decreased by 32.2% year-over-year, from $1.38B to $936.72M.
- What is the long-term trend for Janux Therapeutics's market capitalization?
- Over 4 years (2021 to 2025), Janux Therapeutics's market capitalization has grown at a 0.5% compound annual growth rate (CAGR), from $815.15M to $830.04M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Janux Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude